Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.3%1-day move

₹707.10

prior close

₹704.70

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.3+0.0-0.2-0.3+0.6+3.5-1.8-7.4-9.3-12.3-4.1-1.0—

Up moveDown movePending

AI summary

Aarti Pharmalabs Limited has scheduled an Earnings Conference Call for investors and analysts on Tuesday, May 26, 2026, at 4:00 PM IST to discuss the company's Q4 FY26 financial results. The call is hosted by YES Securities (India) Ltd. Key management participants include Chairman Mr. Rashesh Gogri, Vice Chairperson and Managing Director Mrs. Hetal Gogri Gala, and CFO Mr. Piyush Lakhani. Investors are required to pre-register via the provided Zoom webinar link. The announcement is filed under SEBI (LODR) Regulation 30.

Likely market impact

The scheduled earnings call signals that Q4 FY26 results are imminent. Investors and analysts should monitor for the actual results release around May 26, 2026, which could impact the stock price.